Upper and Lower System Nasolacrimal Duct Stenosis Secondary to Paclitaxel
Authors:
- Emily McCartneyEMEmily McCartney
- Shailaja ValluriSVShailaja Valluri
- Dan RushingDRDan Rushing
- Richard BurgettRBRichard Burgett
- 1 March 2007
- journal article
- case report
- Published by Wolters Kluwer Health in Ophthalmic Plastic & Reconstructive Surgery
- Vol. 23 (2) , 170-171
Abstract
A 66-year-old man underwent chemotherapy and radiation for angiosarcoma of the head and neck. Paclitaxel was used in his chemotherapeutic regimen. Two months post treatment with paclitaxel, he developed epiphora. He was found to have severe punctal and canalicular stenosis at the time of surgery.Keywords
This publication has 5 references indexed in Scilit:
- Docetaxel-Induced Histologic Changes in the Lacrimal Sac and the Nasal MucosaOphthalmic Plastic & Reconstructive Surgery, 2003
- Erosive Conjunctivitis and Punctal Stenosis Secondary to Docetaxel (Taxotere)Eye & Contact Lens: Science & Clinical Practice, 2003
- Canalicular stenosis secondary to weekly docetaxel: a potentially preventable side effectAnnals of Oncology, 2002
- Canalicular Stenosis as the Underlying Mechanism for Epiphora in Patients Receiving Weekly DocetaxelThe Oncologist, 2001
- Canalicular stenosis secondary to docetaxel (taxotere)Ophthalmology, 2001